EVIO Inc
OTC:EVIO
Relative Value
There is not enough data to reliably calculate the relative value of EVIO.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
EVIO Competitors Multiples
EVIO Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
EVIO Inc
OTC:EVIO
|
19.2k USD | 0 | -0 | -2.7 | -2.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 370.3 | 4 385.2 | 1 390.4 | 2 970.6 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
194.5B USD | 4.4 | 29 | 20.2 | 27.1 | |
| US |
|
Danaher Corp
NYSE:DHR
|
148.2B USD | 6 | 41 | 22.7 | 34.6 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
138.8T KRW | 25.2 | 87 | 51.3 | 68.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.3B CHF | 5.6 | 38.3 | 28.4 | 28.4 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
280.3B CNY | 6.3 | 18.7 | 18.9 | 18.9 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
35.5B USD | 5.1 | 27.2 | 19.8 | 23.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28.3B USD | 7 | 32.4 | 23.9 | 26.6 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
27.8B USD | 1.7 | 20.5 | 11.6 | 17.3 | |
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
167.6B HKD | 7.3 | 35 | 24.6 | 24.6 |